New Delhi, 22 ga Yuni (Xinhua) ya nuna ingancin kashi 77.8 cikin dari na III, da yawa a ranar Talata.
"Bharat Biorcoch na COAXIN na 77.8 cikin dari yana da inganci wajen kare CoviD-19, a cewar masu shari'ar III a kan mahalarta 25 zuwa kungiyar Indiya," in ji rahoton.
Matsalar ta fito a ranar Talata bayan mai sarrafa magunguna na kwararrun kwamitin Indiya (Sec) sun hadu da tattauna sakamakon.
FASAHA MAI KYAU YANA CIKIN SAUKI NA NII don maganin gwaji ga DCGI a karshen mako.
Rahotanni sun ce ana sa ran kamfanin zai gudanar da ganawa a kan hukumomin hukumomin duniya a ranar Laraba, don tattauna jagororin da ake buƙata da takardu na ƙarshe.
Indiya ta fara yin rigakafi da COVID-19 a Janairu 16 a Janairu ta 16 ta gudanar da rigakafin rigakafi guda biyu, wato Covishield da COAVOXIN.
Cibiyar da ke cikin India (sii) ita ce masana'antar Astrazena-Oxford Jami'ar Copea-Oxford Jami'ar Copech, yayin da Bharat m Biotech ya hade tare da Majalisar India na Binciken India (iCmr) a masana'antar COAXIN.
Harshen sputnik V alurar riga kafi shi ma an ma yi birgima a cikin kasar. Ƙare ƙarshe
Lokaci: Jun-25-2021